CARE-BOOK_1170x120_5-3-21

CHPA

CHPA issues statement regarding announcement of Patrizia Cavazzoni as FDA’s new CDER director

CHPA issues statement regarding announcement of Patrizia Cavazzoni as FDA’s new CDER director

WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from Scott Melville, president and CEO, in response to the announcement that Patrizia Cavazzoni will succeed Janet Woodcock as the permanent director of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research: “CHPA congratulates Patrizia Cavazzoni on her recent

Xavier Becerra confirmed as Biden’s health secretary

Xavier Becerra confirmed as Biden’s health secretary

WASHINGTON — The Senate on Thursday confirmed California Attorney General Xavier Becerra as President Joe Biden’s health secretary, filling a key position in the administration’s COVID-19 response and its major push to lower drug costs, expand insurance coverage, and eliminate racial disparities in medical care. The 50-49 vote makes the 63-year-old Becerra the first Latino

CHPA issues statement regarding ODSP leadership

CHPA issues statement regarding ODSP leadership

WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement regarding the changes in leadership at the FDA Office of Dietary Supplement Programs (ODSP), including Director Steven Tave’s appointment to lead the Office of Regulatory Affairs (ORA) Office of Strategic Planning and Operational Policy, and Dr. Cara Welch’s appointment as Acting Director of

CHPA comments on CBD Bill

CHPA comments on CBD Bill

WASHINGTON— Scott Melville, president and CEO of the Consumer Healthcare Products Association (CHPA) applauded the introduction of the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, that was introduced on Thursday. CHPA has also become part of a larger coalition of organizations who support the bill. “We’re encouraged that this legislation

National survey shows slight increase in teen abuse of O-T-C cough medicine

National survey shows slight increase in teen abuse of O-T-C cough medicine

WASHINGTON — The results of the 2020 National Institute on Drug Abuse (NIDA) and University of Michigan’s Monitoring the Future survey shows 3.7% of teens reported using over-the-counter (OTC) cough medicine containing dextromethorphan (DXM) to get high, an increase from 2.8% in 2019. While overall rates remain low, NIDA’s survey release notes that use among eighth

New CHPA website offers more for members and industry

New CHPA website offers more for members and industry

WASHINGTON — The Consumer Healthcare Products Association (CHPA) continued its rebranding effort which began earlier this year with the recent launch of a new flagship website, www.CHPA.org. The association’s new interactive site includes expanded information and resources for the personal healthcare industry — which includes over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. The

The Nature’s Bounty Co. joins CHPA

The Nature’s Bounty Co. joins CHPA

WASHINGTON – The Nature’s Bounty Co., a global leader in health and wellness, has joined the Consumer Healthcare Products Association (CHPA) as its newest member. Nearly half of CHPA’s current members manufacture or market dietary supplements in addition to either over-the-counter (O-T-C) and/or consumer medical device products, but The Nature’s Bounty Co. – a manufacturer

Supplement and Hemp Industry Associations applaud bipartisan legislation to regulate hemp-derived CBD

Supplement and Hemp Industry Associations applaud bipartisan legislation to regulate hemp-derived CBD

WASHINGTON – The four leading dietary supplement industry associations applaud Representative Kurt Schrader (D, Ore.) and Representative Morgan Griffith (R,Va.), for introducing bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. The Hemp and Hemp derived CBD Consumer Protection and Market Stabilization Act of 2020 directs the

CHPA makes statement on ‘Buy American’ executive order

CHPA makes statement on ‘Buy American’ executive order

WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement Thursday in response to the Trump Administration’s “Buy American” Executive Order (EO) for essential pharmaceuticals: “Over-the-counter (O-T-C) drug manufacturers have been working tirelessly to ensure American consumers have a continued supply of O-T-C medicines to treat a wide variety of ailments, such as

Video Forum: Scott Melville, CHPA

Video Forum: Scott Melville, CHPA

The latest installment in our Video Forum features Scott Melville, president and chief executive officer of the Consumer Healthcare Products Association. In addition to the rebranding of CHPA, Melville talks about what recently enacted O-T-C monograph reform means for the category, and the increasingly important part that nonprescription products are playing in health care.

CHPA issues statement regarding O-T-C measures in COVID-19 legislation

CHPA issues statement regarding O-T-C measures in COVID-19 legislation

WASHINGTON— Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act, which among its many sections includes provisions to update and modernize the regulatory system overseeing most over-the-counter (O-T-C) medicines and to restore O-T-C eligibility under tax-preferred HSA and FSA accounts. “During this unprecedented

Supplement industry associations applaud FDA actions to protect consumers from fraudulent products related to COVID-19

Supplement industry associations applaud FDA actions to protect consumers from fraudulent products related to COVID-19

WASHINGTON — The U.S. dietary supplement industry commends the Food and Drug Administration (FDA) for taking action to protect consumers by calling out marketers who make illegal and unsubstantiated drug claims related to COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.   In February, the industry issued strong warning to companies and consumers to avoid

Pharmacy Outlook: Scott Melville, CHPA

Pharmacy Outlook: Scott Melville, CHPA

Welcome to 2020, where, more than ever, patients and caregivers are taking control of their health care decisions and an increasing array of consumer health care products is helping them get well, stay healthy, treat minor ailments and even manage some chronic conditions. The marketplace is evolving before our eyes, including the manufacturers, who are

1 2 3